All stakeholders have a role in ensuring Canada can attract research and new medicine launches as we rebuild from the pandemic. In this context, LSO has provided a number of general recommendations and considerations to help guide the PMPRB’s approach for its interim guidelines period and beyond.
Read LSO’s submission to learn more LSO_PMPRB interm guidelines submission_Final
